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Endovascular stenting in the treatment of pelvic
vein congestion caused by nutcracker syndrome:
Lessons learned from the first five cases
Olivier Hartung, MD, Dominique Grisoli, MD, Mourad Boufi, MD, Ivo Marani, MD,
Zaher Hakam, MD, Pierre Barthelemy, MD, PhD, and Yves S. Alimi, MD, PhD, Marseille, France
Background: Compression of the left renal vein between the aorta and the superior mesenteric artery is a rare but possibly
underestimated condition. Surgical correction (42 cases reported in the literature) can be performed by means of a variety
of different techniques. Although endovascular stenting is well accepted for iliocaval occlusive disease, it has been poorly
evaluated in this indication. We describe five patients who were treated for nutcracker syndrome by using stenting and
analyze the nine cases previously reported.
Methods: From November 2002 to September 2004, five women (mean age, 34.7 years) were admitted for endovascular
treatment of a nutcracker syndrome. They all had incapacitating pelvic congestion syndrome, including twowith a history
of left ovarian vein embolization; moreover, two had left lumbar pain, and three had hematuria. The mean preoperative
venous disability score was 2.4. The patients underwent a gynecologic examination and laparoscopy to eliminate other
causes of pelvic pain. The laparoscopy revealed large pelvic varicose veins and no signs of endometriosis. Duplex scan,
computed tomographic scan, and iliocavography revealed left renal vein compression, with proximal distention and
collateral pathways, with dilatation and permanent reflux in the left ovarian vein in the three patients who had not had
prior embolization. The mean renocaval pullback gradient was 4.3 mm Hg. A percutaneous endovascular procedure,
during in which a self-expanding metallic stent was implanted, was performed under general anaesthesia.
Results: Technical success was achieved in all cases. One case of stent migration occurred: the stent was pulled down in the
inferior vena cava, with uneventful follow-up (mean, 14.3 months). One month later, patients were all improved and
stents were patent at the duplex scan examination, without restenosis. The mean venous disability score was 1. No further
left ovarian vein reflux was evident at duplex scan in patients who did not have prior embolization. Pelvic pain recurred
in one patient who had initially improved, and endometriosis was diagnosed 15 months after the procedure. Two other
patients, who received 40-mm-long stents, had a secondary recurrence of the symptoms caused by stent dislodgement.
The two other patients were asymptomatic.
Conclusions: This study shows that stenting is feasible, but some guidelines should be followed, mainly the use of long
stents protruding into the inferior vena cava. Stenting can eliminate the symptoms of the condition, and the technique is
only very slightly invasive. Further experience and follow-up are needed before accepting such a procedure for treatment
of the nutcracker syndrome. (J Vasc Surg 2005;42:275-80.)The endovascular treatment of large-vein occlusive dis-
ease is well accepted for iliocaval and superior vena cava
lesions. Many publications have shown that it is feasible,
effective, and safe.1-2 In addition, the midterm results are
satisfactory.
The nutcracker phenomena is caused by arterial com-
pression of the left renal vein between the superior mesen-
teric artery and the aorta.3 It is symptomatic on occasion
and can even be incapacitating. As stenting has given good
results in the treatment ofMay-Thurner syndrome, another
form of compression of a large vein by an artery, endovas-
cular therapy for the nutcracker syndrome was first pro-
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METHODS
FromNovember 2002 to September 2004, five women
aged 30 to 39 years (mean, 34.7 years) were admitted to
the vascular surgery department for endovascular treatment
of a nutcracker syndrome. All but one had had a previous
pregnancy, and none had a history of deep vein thrombosis.
Two had prior left ovarian vein embolization 19 months
and 13 months before that improved their symptoms for 2
and 3 months, respectively, before recurrence associated
with the development of left lumbar pain. One had had
endovascular stenting for May-Thurner syndrome. Pelvic
surgery had previously been performed in three: a left
ovariectomy in one, for a left ovarian cyst in one, and a right
ovariectomy in one. One patient had a history of bilateral
great saphenous vein stripping.
All of the patients had long-standing incapacitating
pelvic congestion syndrome (mean duration, 3.4 years).
These symptoms were associated with left lumbar pain in
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tive venous disability score5 was 2.4 (range, 2 to 3). In
addition, one patient had left limb atypical varices with
venous insufficiency symptoms.
Gynecologists had referred all of the patients, and a
complete gynecologic workup was performed, including a
clinical examination, pelvic transparietal and endovaginal
echography, and laparoscopy. In all cases, no other cause of
pelvic pain was found, and the results of echography and
laparoscopy showed the presence of large varices around
the uterus (left side only in three).
After 3 days of a no-residue diet, a duplex scan was
performed on an empty stomach in our department with a
Toshiba Powervision SSA 380A and a 3-6MHz probe. The
celiac region was examined with horizontal, sagittal, and
transversal sections. In cases of nutcracker syndrome, the
left renal vein was stenosed between the superior mesen-
teric artery and the aorta, and this was always associated
with proximal left renal vein dilatation (Fig 1). Flow was
absent or at least there was no respiratory fluctuation. Left
ovarian vein dilatation with permanent reversed flow was
found in three patients (two patients had left ovarian vein
occlusion caused by a prior embolization).
Angio computed tomographic (CT) scan showed left
renal vein stenosis (Fig 2, A) with proximal dilatation (Fig
2, B). In the three patients with a patent left ovarian vein, it
was dilated and quickly became opacified (Fig 2, C).
The procedures were performed in the operating room
with a portable C arm. Under local anesthesia, a percuta-
neous puncture of the left common femoral vein gave
access to a 7F sheath. Selective catheterization of the left
renal vein was performed with a 7F RDC guiding catheter
(Cordis, Johnson & Johnson, Miami, Fla) and a 5F
Cobra angiographic catheter (Cook, Bloomington, Ind). A
ngiography was performed, and in all cases, it revealed dye
stagnation in the left renal vein with opacification of the
collateral pathways (Fig 3, A). In the three previously
nonembolized patients, the left ovarian vein was dilated
and opacified down to the pelvis. The renocaval pullback
gradient was 4 to 5 mm Hg (mean, 4.3 mm Hg).
Once nutcracker syndrome was confirmed, general an-
esthesia and intravenous heparin were given. An 11F sheath
was inserted into the left common femoral vein and the
Terumo guidewire (Tokyo, Japan) was changed for an
Amplatz Super Stiff guidewire (Boston Scientific, Natick,
Mass). Angioplasty was first performed with a 15-mm-
diameter balloon (Maxi LD, Cordis, Johnson & Johnson).
A self-expanding metallic stent (Wallstent, Boston Scientific-
Schneider,Minneapolis, Minn) was then deployed in the left
renal vein and dilated with a balloon. Completion angiogra-
phy was performed before the sheath was retrieved (Fig 3, B).
Follow-up was performed by clinical examinations and
duplex scanning at 1, 3, 6, and 12 months, and then yearly
or if symptoms recurred. In that case, or if changes were
noted on the duplex scan, a CT scan and an angiography
were performed.RESULTS
Technical success was achieved in all patients. Angio-
plasty alone, although there was no residual mark on the
balloon when inflated, always failed to relieve the stenosis.
The first patient received a 20-mm-diameter, 60-mm-long
Wallstent that migrated into the retrohepatic inferior vena
cava and was pulled down 5 cm with an Amplatz Goose
Neck Snare Kit (ev3 Inc, Plymouth, Minn). However, it
adopted a transversal position in the inferior vena cava just
cephalad to the left renal vein and was left in place because
further attempts failed. A 16-mm-diameter stent was then
deployed in this patient and in the other patients as well.
No postoperative complications occurred. All patients
received low-molecular-weight heparin after the operation
and were discharged on nadroparin for 15 days and clopi-
dogrel for at least 6 months. Two patients were also given
fluindione for 6 months.
Follow-upwas4.2 to26.5months (mean,14.3months).At
1 month, all patients had improved. A duplex examination
showed the absence of residual stenosis with a good flow in
the left renal vein. No further left ovarian vein reflux was
observed on the duplex scan of the patients who did not
have prior embolization. Although we do not have a ratio-
nal explanation—unless it would be unseen collateral path-
ways—surprisingly, the two patients with prior emboliza-
tion had improvement not only of the left flank pain but
also of the pelvic congestion syndrome.
Two patients who received a 40-mm-long, 16-mm-
diameter Wallstent had recurrence of the symptoms at 3
and 4 months postoperatively. In both, duplex and CT
scanning showed that the stent had moved to the right side
of the inferior vena cava, allowing the superior mesenteric
artery to compress the left renal vein (Fig 4). Both patients
are currently under close surveillance.
Different pelvic pain developed in one patient at 15
months. Imaging techniques found endometriosis, even
though no signs of endometriosis had been found 17
months before at the preoperative workup (pelvic echogra-
phy, duplex scan, CT scan, and laparoscopy). A hysterec-
tomy was performed after medical treatment failed.
The two other patients are asymptomatic at 4.2 and
26.5 months after the procedure.
DISCUSSION
The nutcracker syndrome is a relatively rare—but may
be underestimated—entity that can need correction. Pas-
tershank6 was the first to propose surgical treatment of this
condition. To date, 42 cases treated by a variety of tech-
niques other than endovascular stenting have been re-
ported (Table I).6-23 All of these procedures gave good
results, but they are invasive and even sometimes radical,
such as nephrectomy.23
Although most of the cases reported occurred in
men,18 only women were in our cohort, because they were
all initially referred for pelvic congestion syndrome.24 Their
venous disability score was 2, and all of these young
women had been limited in their activities for5 years. The
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because we initially failed to diagnose the nutcracker syn-
drome on the duplex scan. The diagnosis was made at
follow-up when the patients came back with left lumbar
pain and recurrent pelvic pain.
Our experience leads us to believe that the diagnostic
criteria on imaging techniques (duplex scan, CT, magnetic
resonance angiography, angiography) should associate left
renal vein stenosis with proximal distention and the pres-
ence of collateral pathways. It must be emphasized that
Fig 1. Duplex scan view of the nutcracker sy
Fig 2. Angio computed tomography scan aspect of a p
vein between the superior mesenteric artery and the aor
(black arrow). C, Dilatation and early opacification of th
Fig 3. Angiographic view of the nutcracker syndrome. A
collateral pathways (left gonadic vein, hemiazygos vein).B
collateral pathways have disappeared and the left renal vstenosis is not always well highlighted by angiography. Anintravascular ultrasound scan could visualize it more accu-
rately, as it does in May-Thurner syndrome.25 The main
collateral pathway is the left gonadic vein, which was dilated
and incompetent in all of our patients; this sign can be seen
on CT scan, as it has early contrast enhancement during the
portal phase.
Treatment was decided when the patients had clinical
signs of incapacitating nutcracker syndrome (left flank pain,
hematuria), or pelvic congestion syndrome (after elimina-
tion of others causes by a complete workup including
me on (A) sagittal and (B) transversal sections.
with nutcracker syndrome. A, Stenosis of the left renal
ack arrow). B, Proximal dilatation of the left renal vein
ovarian vein (black arrow).
nosis of the left renal vein with dye stagnation and large
ssive reflux in the left gonadic vein.C,After stenting, the
well opacified.ndroatient
ta (bl, Ste
,Malaparoscopy), or both, associated with a significant stenosis
ferio
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CT scan, and angiographic and renocaval pullback gradient
(3 mm Hg) criteria.
As we have some experience in venous stenting for
iliocaval occlusive disease,2 we have been very interested in
the first cases of stenting to treat nutcracker syndrome. So
far, nine cases of endovascular stenting have been published
worldwide (Table II).4,13,18,26-29
Some technical points should be emphasized. General
anesthesia was used because our experience in May-
Thurner syndrome under local anesthesia revealed that
stent deployment and angioplasty are very painful in that
specific indication. Moreover, the postoperative course
showed that lumbar pain was present for a few days.
The left common femoral vein should be preferred for
Fig 4. Stent displacement after 3 months. A, Compute
the inferior vena cava and the superior mesenteric artery
Angiography shows the stent largely protruding in the in
Table I. Published cases of treatment of nutcracker
syndrome without endovascular stenting
Technique (references) N Complications Results
LRV transposition7-13 18 2 RPH Asymptomatic, 17
2 ileus Hematuria, 1
1 DVT
Autotransplantation14-15 7 Asymptomatic, 7
LRV bypass16 5 Asymptomatic, 4
Improved, 1
External stenting17-18 3 Asymptomatic, 3
Gonadocaval bypass18 3 Residual
gradient 2
Improved, 3
SMA transposition19 1 Asymptomatic, 1
Surgical angioplasty20 1 Asymptomatic, 1
Renal fixation21 1 Asymptomatic, 1
LRV phlebolysis6 1
BA22 1 Asymptomatic, 1
Nephrectomy23 1
Total 42 Asymptomatic, 35
Improved, 5
Unknown, 2
LRV, Left renal vein; SMA, superior mesenteric artery; BA, balloon angio-
plasty; RPH, retroperitoneal hematoma; DVT, deep vein thrombosis.percutaneous access to make left renal vein catheterizationeasier. A super stiff guidewire is needed and should be
placed downwards in the left gonadic vein to allow the stent
to cross the stenosis. Then the guidewire should be re-
trieved and pushed away cautiously into the renal vein
before stent deployment.
One of the main technical end points is the type of stent
to use. According to Raju1 and our own experience2,30 in
venous stenting, self-expanding retrievable metallic stents
should be used, and the Wallstent is the only commercially
available stent that has all these criteria. In line with Se-
gawa,26 we used a 20-mm-diameter stent for our first
patient. The stent was correctly positioned, but it moved
into the inferior vena cava during balloon angioplasty. An
attempt to retrieve it with a Goose Neck failed when the
stent took a transversal orientation after 5 cm, and further
attempts failed. Despite the risk of thrombosis, we decided
not to perform surgery. The patient received fluindione for
6 months and clopidogrel for 1 year, and no complications
had occurred after 26 months.
This complication was caused by the anatomy of the left
renal vein. The length on the left side of the superior
mesenteric artery is too short to put the stent in while
staying in its trunk, so during angioplasty, the stent short-
ened, then was not stabilized on both side of the stenosis,
and moved. We then used a 16-mm-diameter Wallstent
with an excellent result.
For patients 1 and 2, we used 60-mm-long stents, and
angiographic control showed they were slightly protruding
into the inferior vena cava. For the two next patients,
40-mm-long stents were used, with an excellent comple-
tion angiography. Symptoms disappeared until the third
and the fourth month, when both patients had secondary
stent dislodgement. These complications proved the effi-
ciency of the treatment but also showed that 40-mm-long
stents are too short. Lin13 had the same complication using
a 12-mm-diameter, 40-mm-long, Wallstent.
We now believe that the 16-mm-diameter, 60-mm-
long Wallstent should be considered as the base of sizing
ography scan shows the stent lying on the right side of
ressing the left renal vein on the left side of the stent. B,
r vena cava.d tom
compfor left renal vein stenting but should be fit to patient
, Mem
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procedure. As with all venous stenoses, stents need to be
stabilized, so long stents that lean on both sides of the
stenosis should be used.
Protrusion of the stent in the inferior vena cava does
not seem to cause any complication. It can be assimilated to
what Raju1 recommended to do for stenting in the May-
Thurner syndrome: stent largely protruding into the infe-
rior vena cava. In our own experience of venous stenting,
two stents were left in a transversal position in the inferior
vena cava after migration during stenting without adverse
effect after 26 and 48 months. Moreover, inferior vena cava
filters, althoughmainly inserted in case of thrombotic event
and in most cases without heparin or warfarin therapy, have
long-term patency rates of 90% at 10 years.31
Postoperative drug treatment is an important issue.
Three patients were given low-molecular-weight heparin
for 15 days and clopidogrel for 6 months, like we com-
monly do for May-Thurner syndrome. These durations
were chosen empirically, as no guidelines for drug therapy
exist. Two patients were also given fluindione, one because
the stent migrated into her inferior vena cava and the other
at the surgeon’s choice.
CONCLUSION
The nutcracker syndrome is an emerging indication for
venous endovascular stenting. This only slightly invasive
treatment can eliminate the symptoms of the condition.
Stenting can be used, provided that the same techniques as
those in the May-Thurner syndrome are used, that is, the
stent should protrude into the inferior vena cava. Further
studies should report if this approach has adverse effects
and if such a treatment can be accepted.
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